Students gain voting rights in Graduate School governance

Graduate students serving on the General Committee of the Graduate School now have full voting privileges on legislation and policy, the Graduate School has announced.

Physicists turn toward heat to study electron spin

Cornell physicists offer a solution to control the intrinsic spin of electrons: Using heat, instead of light, to measure magnetic systems at short length and time scales.

Chemist Will Dichtel earns MacArthur 'Genius Award'

Will Dichtel, associate professor of chemistry and biochemistry, whose innovations may allow for ample electricity and for detecting trace amounts of explosives, has received a 2015 MacArthur Foundation Fellowship.

Graduate students earn record number of NSF fellowships

Cornell gives its graduate students an edge in competing for NSF research fellowships, with resources including workshops and writing seminars. There are currently 249 fellowship recipients on campus.

Child care funding for students with children more than doubles

The deadline for students with children to apply for child care grant funding is Oct. 16. The funding available for 2015-16 is more than double what it was last year.

Robin Davisson to lead Melanoma Research Alliance

Robin Davisson, the Andrew Dickson White Professor of Molecular Physiology at Cornell, will become president and CEO of the Melanoma Research Alliance effective Oct. 1.

Cornell Rewind: Exploring our world and beyond

Not long after Cornell University opened its doors, professors organized expeditions. For 150 years, the faculty and students have traveled around our globe and others.

Garrett highlights initiatives, progress at GPSA meeting

Increases in support for child care and research assistant stipends and a reduced tuition for self-pay doctoral students in their sixth or seventh year were announced Aug. 31 at the Graduate and Professional Student Assembly meeting.

Antibody-making bacteria promise drug development

A team of Cornell chemical engineers and New England Biolabs scientists have devised a method for churning out complex proteins, including many of today's blockbuster, life-saving antibody drugs, in as little as a week.